GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

CT-179   Click here for help

GtoPdb Ligand ID: 14252

Synonyms: compound 8 [WO2016138479] | CT179
Compound class: Synthetic organic
Comment: CT-179 is a brain-penetrant, orally bioavailable OLIG2 (oligodendrocyte transcription factor 2) inhibitor. It has shown efficacy in targeting OLIG2+ve medulloblastoma stem cells in vitro and in vivo [2-3]. It is one of the OLIG2 inhibitor compounds claimed in Curtana Pharmaceuticals patent WO2016138479A1 [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 81.12
Molecular weight 397.3
XLogP 0.84
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=NC(=NC(=C1)NCCCN(C)C)NC(=O)NC2=CC=C(C(=C2)Cl)Cl
Isomeric SMILES CN(C)CCCNC1=CC(C)=NC(NC(NC2=CC(Cl)=C(Cl)C=C2)=O)=N1
InChI InChI=1S/C17H22Cl2N6O/c1-11-9-15(20-7-4-8-25(2)3)23-16(21-11)24-17(26)22-12-5-6-13(18)14(19)10-12/h5-6,9-10H,4,7-8H2,1-3H3,(H3,20,21,22,23,24,26)
InChI Key MWEZWAONAIZIAQ-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
The US FDA has granted CT-179 orphan drug designation in 2017, to treat gliomas in adults and children.